HUP0303500A2 - Eljárás szexuális rendellenességek kezelésére bombezin-antagonisták segítségével - Google Patents

Eljárás szexuális rendellenességek kezelésére bombezin-antagonisták segítségével

Info

Publication number
HUP0303500A2
HUP0303500A2 HU0303500A HUP0303500A HUP0303500A2 HU P0303500 A2 HUP0303500 A2 HU P0303500A2 HU 0303500 A HU0303500 A HU 0303500A HU P0303500 A HUP0303500 A HU P0303500A HU P0303500 A2 HUP0303500 A2 HU P0303500A2
Authority
HU
Hungary
Prior art keywords
treatment
sexual dysfunction
bombesin antagonist
bombesin
bombesin receptor
Prior art date
Application number
HU0303500A
Other languages
English (en)
Inventor
Maria Isabel Gonzalez
Michael Higginbottom
Robert Denham Pinnock
Martyn Clive Pritchard
Herman Thijs Stock
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of HUP0303500A2 publication Critical patent/HUP0303500A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány bombezin receptor antagonista hatású, nempeptid vegyületekés peptidek alkalmazására vonatkozik, mind nők, mind férfiak szexuálisrendellenességeinek kezelésére szolgáló gyógyszerkészítményekelőállítására. A bombezin receptor antagonista hatású vegyületetelőnyösen helyi értágítókkal, PDE5 inhibitorokkal, VIP fokozókkal,angitenzin-2 receptorral, neurotranszmitterekkel és szteroidhormonokkal kombinálják. Ó
HU0303500A 2000-11-17 2000-11-17 Eljárás szexuális rendellenességek kezelésére bombezin-antagonisták segítségével HUP0303500A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2000/004380 WO2002040022A1 (en) 2000-11-17 2000-11-17 Treatment of sexual dysfunction using bombesin antagonist

Publications (1)

Publication Number Publication Date
HUP0303500A2 true HUP0303500A2 (hu) 2004-01-28

Family

ID=9886325

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303500A HUP0303500A2 (hu) 2000-11-17 2000-11-17 Eljárás szexuális rendellenességek kezelésére bombezin-antagonisták segítségével

Country Status (13)

Country Link
EP (1) EP1333829A1 (hu)
JP (1) JP2004525864A (hu)
KR (1) KR20040062416A (hu)
CN (1) CN1479618A (hu)
AU (1) AU2001214046A1 (hu)
BR (1) BR0017374A (hu)
CA (1) CA2426521A1 (hu)
HU (1) HUP0303500A2 (hu)
IL (1) IL155814A0 (hu)
MX (1) MXPA03003481A (hu)
PL (1) PL366002A1 (hu)
WO (1) WO2002040022A1 (hu)
ZA (1) ZA200303250B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10123163A1 (de) 2001-05-09 2003-01-16 Gruenenthal Gmbh Substituierte Cyclohexan-1,4-diaminderivate
US7244743B2 (en) 2002-06-05 2007-07-17 Solvay Pharmaceuticals Gmbh Non-peptidic BRS-3 agonists
CN117665174B (zh) * 2024-02-01 2024-04-23 巴中市产品质量检验检测中心 一种检测pde5和ssri的方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369094A (en) * 1990-11-29 1994-11-29 The Administrators Of The Tulane Educational Fund Polypeptide bombesin antagonists
US5650395A (en) * 1995-03-13 1997-07-22 Hurel; Steven Treatment of pulmonary hypertension
WO1998007718A1 (en) * 1996-08-22 1998-02-26 Warner-Lambert Company Non-peptide bombesin receptor antagonists
AU2180600A (en) * 1998-12-18 2000-07-12 Warner-Lambert Company Non-peptide nk1 receptors antagonists
AU4825200A (en) * 1999-05-07 2000-11-21 Board Of Regents, The University Of Texas System Oral steroidal hormone compositions and methods of use
ES2183500T3 (es) * 1999-06-04 2003-03-16 Jordanian Pharmaceutical Mfg A Nuevos compuestos y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
CN1479618A (zh) 2004-03-03
WO2002040022A1 (en) 2002-05-23
CA2426521A1 (en) 2002-05-23
KR20040062416A (ko) 2004-07-07
IL155814A0 (en) 2003-12-23
ZA200303250B (en) 2004-04-26
MXPA03003481A (es) 2004-09-10
JP2004525864A (ja) 2004-08-26
EP1333829A1 (en) 2003-08-13
AU2001214046A1 (en) 2002-05-27
PL366002A1 (en) 2005-01-24
BR0017374A (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
CY1108562T1 (el) Μεθοδοι για την προληψη προσληψης βαρους η οποια προκαλειται απο αντιψυχωτικες θεραπειες
PL373001A1 (en) Combination of azelastine and steroids
PL376440A1 (en) Pyridopyrrolizine and pyridoindolizine derivatives
ATE340796T1 (de) Dihydropyrrolo(1,2-aöindol- und tetrahydropyrido)1,2-aöindolderivate als prostaglandin rezeptor antagonisten
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
TW200605880A (en) Progesterone receptor antagonist contraceptive regimens and kits
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
HUP0301892A2 (hu) Szexuális zavarok kezelésére szolgáló gyógyszerkészítmények és előállításuk
MXPA06013133A (es) Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina.
HUP0100705A2 (hu) Hatóanyag-kombinációk alkalmazása, valamint ilyen kombinációkat tartalmazó gyógyszerkészítmények és készletek impotencia kezelésére
AU2001285318A1 (en) Use of an aldosterone receptor antagonist to improve cognitive function
WO2002076390A3 (en) Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
HUP0401805A2 (hu) Pulmonális betegségek kezelésére szolgáló vegyületek
WO2003101455A3 (en) Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
HUP0303500A2 (hu) Eljárás szexuális rendellenességek kezelésére bombezin-antagonisták segítségével
RS78004A (en) Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
EP1246619A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
NO20062883L (no) Fosfodiesterase-V-inhibitorpreparater
NO20041338D0 (no) Fremgangsmate ved inhibering av kognitiv svekkelse hos voksne med Downs syndrom.
CL2004001317A1 (es) Composicion farmaceutica que comprende el antagonista de receptores de progesterona 11b-(4-acetilfenil)-17b-hidroxi-17 alfa-(1,1,2,2,2-pentafluoroetil)-estra-4,9-dien-3-ona y un antiestrogeno puro; y su uso para tratar una enfermedad dependiente de h
SE0202365D0 (sv) New formulation and use thereof
GT200200003A (es) Antagonistas de receptores de histamina
EP1395593A4 (en) NEW PYRAZOLOPYRIMIDINTHION DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AS A THERAPEUTIC IN ERECTILER DYSFUNCTION
CA2548078A1 (en) Pharmaceutical formulations of camptothecins and process for making same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees